Discover the first predictive therapy decision support tool

PredictionStar is an innovative aid for Breast Cancer physicians and patients, deserving optimal therapy.

Tumor typing has never facilitated optimal treatment with predictable outcomes – until now.

Empowering optimal therapies with
predictable outcomes – every patient!

All of this, highly cost-effectively and neutral for health care budgets.

Our Approach

PredictionStar is the first of its kind point-of-care technology platform, amenable to any cancer hospital.

The technology works by using patented algorithms for analysis of tumor-specific genomic, biological, pathological, and patient-specific clinical information, complemented by intelligence-augmented drug – tumor matching, calibration with real-world outcome data to guide evidence-based therapy decisions.

The ubiquitious risk of suboptimal treatment choice makes PredictionStar a must-have therapy decision support tool.

Onco Genom X - PredictionStar - Approach 2

40% of patients with advanced breast cancer (aBC) are eligible for costly molecularly targeted combination treatment¹. In more than 60% of patients, the disease progresses within 2 years². Type 3 aBC has a higher than 80% chance of progressing within 1 year³. Study OGX-1019-HE0033 that evaluated guideline conform first- and second line treatment of advanced stage patients revealed alarming insights of high clinical relevance:

  • The annual spendings of a cancer hospital for anticancer therapies required for 200 aBC patients amounts to 20M USD.
  • 9M USD thereof are spent for anticancer treatments unlikely to work for tumor-specific biological reasons.

Support

The PredictionStar approach goes beyond cancer profiling and easy-to-read therapy guidance through a routine-fit application on a mobile device.

To maximize the clinical utility, PredictionStar offers an effortless and intuitive feedback routine powered by advanced machine learning for continuous improvement of therapy decision support and increasing numbers of patients benefitting from PredictionStar use.

Onco Genom X - PredictionStar - Support

Our team

We have assembled a team of 7 accomplished industry pioneers with complementary expertise, including company-building, diagnostics platform-building, clinical oncology, and molecular cancer diagnostics. 

We are united by the passion of making PredictionStar a diagnostic routine for all Breast Cancer patients, as the steppingstone to biology- and clinical evidence-guided cancer therapy.

Award Top oncology solutions provider in Europe 2022
Award BW Awards CEO 2023
Award Europe's Top 5 Effective Leaders in Healthcare
OncoGenomX - Wolfgang Hackl

Wolfgang Hackl, Founder

Lead Physician
20+ years experience in developing and registering molecular cancer treatments

OncoGenomX - David Demanse

David Demanse, Founder

Lead Data Scientists
15+ years experience in clinical statistics and prediction modelling

OncoGenomX - Karl Andersson

Karl Andersson, Partner

Lead Engineer
20+ years experience in test development and diagnostic instrument engineering

OncoGenomX - Stephanie Harloff

Stephanie Harloff, LLM

Legal Advisor
20+ years experience in Pharma Law, Partnering & Digital Health

OncoGenomX - Annika Remaeus

Annika Remaeus, Partner

Projekt Management, Project Coodination
20+ years experience in IVD platform development and implementation

OncoGenomX - Seppo Maekinen

Seppo Maekinen, Partner

Financing & Partnerships
Investor, VC partner, serial founder
25+ years experience in the investment and IVD industry

OncoGenomX - Marco Witteveen

Marco Witteveen, Partner

Commercialization
20+ years experience in strategic marketing & sales at global IVD companies

OncoGenomX - Annika Remaeus

Annika Remaeus, Partner

Projekt Management, Project Coodination
20+ years experience in IVD platform development and implementation

OncoGenomX - Seppo Maekinen

Seppo Maekinen, Partner

Financing & Partnerships
Investor, VC partner, serial founder
25+ years experience in the investment and IVD industry

OncoGenomX - Marco Witteveen

Marco Witteveen, Partner

Commercialization
20+ years experience in strategic marketing & sales at global IVD companies

Press

Healthcare Tech Magazine

Healthcare Tech

FemTech World Article

FemTech World

Merger Market Article

Merger Market

Business Worldwide Article

Business Worldwide